Speakers

Marco Raddi is Global Pricing Senior Analyst at Chiesi Group, part of its Global Value and Access team, where he works on global pricing and international reference pricing, Gross to Net Management and LSO. He joined Chiesi in 2024 after two years as a Market Access Analyst at Viatris in Italy. There he was part of the Italian pricing and tender team, supporting new launches in oncology, cardiovascular, inflammation and neuroscience. He began his career in value-based healthcare at Roche. A pharmaceutical chemist by training, he holds a master’s degree in Pharmaceutical Chemistry and Technology and a postgraduate master’s in Regulatory Disciplines and Market Access from the University of Piemonte Orientale, and is an EPP Certified Pricing Manager. He recently spoke as a panellist at the Pharma Pricing & Access Innovation Conference in Basel.

Karan Suri is Senior Director of Global Pricing at World Courier, the specialist life sciences logistics company. He leads its global team responsible for pricing strategy, deal desk, pricing operations and negotiations, having joined in 2022 as Director of Pricing Operations. He has more than fifteen years of experience in pricing, revenue management and commercial strategy, most of it in transport. At Heathrow Express he rose from Senior Pricing and Commercial Manager to Head of Commercial Strategy, with responsibility for pricing, marketing, sales and distribution, and digital. Before that he led yield management at Great Western Railway, where he implemented a bespoke in-house revenue management system.

Kaushal Kishore is Pricing, Contracts and Tender Lead in Global Commercial Excellence at Fresenius Kabi. He has twenty years of experience in commercial pricing, tendering and contract management across pharma and medtech. He was previously Director of Strategic Pricing, Tender Management and Analytics at Merck Group, where he led the pricing transformation of its healthcare pharmaceutical portfolio. Before that he held a similar role at Bayer, where he built a global pricing and tendering centre of excellence from scratch for a €5 billion Established Products portfolio. Earlier, he was also instrumental in setting up the pricing, contracts and analytics function in Amgen’s headquarters centre of excellence in Zug, after seven years leading analytics and IT delivery consulting at Wipro. He holds an MBA from T.A. Pai Management Institute and is an EPP Certified Pricing Manager.v

Leandro Gandos Brito is incoming Head of Commercial Policy at Geistlich and a health economist working at the intersection of commercial pricing and global health. He spent fifteen years in pricing, market access and commercial strategy, including five years as Strategic Pricing Director at Sonova, where he led global pricing across more than thirty countries and built its global pricing governance. His health economics research at the Swiss TPH focuses on equitable access to health technologies and interventions in lower-income countries, and he has contributed to World Health Organization (WHO) guidance on malaria strategy. He is completing an MBA in International Health Management at the University of Basel and has spoken at previous editions of the Forum in Berlin and Montreux.

Alexandra Hoos is Market Access Lead at Labatec Pharma SA in Geneva, where she holds full responsibility for the market access strategy across the company’s entire Swiss product portfolio. She joined Labatec more than four years ago as Market Access and Medical Affairs Lead, a dual role that subsequently evolved into a dedicated market access position.

Alexandra has over 13 years of experience in the pharmaceutical industry, predominantly in oncology, and combines commercial, medical, and market access expertise. Prior to Labatec, she spent nearly nine years with the healthcare business of Merck in Switzerland. She began her career there as Oncology Key Account Manager in Zug, then transitioned into medical affairs as Medical Advisor Oncology, before serving almost four years as Market Access Manager. Across her roles at Merck and Labatec, she has accumulated more than eight years of market access experience.

A molecular biologist by training, Alexandra holds a Diploma in Biology from Johannes Gutenberg University Mainz and completed an Erasmus exchange at Cardiff University.

Ayman Semaan is Market Access and Pricing Lead at Biologix, where he has led access and pricing strategy across the Gulf, Levant and North Africa since 2015. His portfolio spans rare diseases, haemato-oncology, neurology, immunology and cardio-metabolic therapies. He has twenty years of experience in the pharmaceutical industry and began his career in sales and marketing at Algorithm Pharmaceutical Manufacturers, latterly as Marketing Manager for cardio-metabolic products across the Middle East and North Africa. He served as Director of Communications for the Lebanese chapter of ISPOR from 2023 to 2025 and is a member of HTAi.

Antoon Boussu is Global Pricing Lead at Novo Nordisk in Copenhagen, where he leads pricing strategy for early- to late-stage assets across cardiometabolic and liver diseases. He also supports business development through pricing and market access due diligence. Before joining the global pricing team in 2024, he held market access roles at Novo Nordisk BeLux and AstraZeneca, covering reimbursement strategy, payer engagement and HTA submissions. He began his career as a business analyst at IM Associates (now part of IQVIA). He holds an MSc in Pharmaceutical Sciences (Drug Development) from KU Leuven and a Master in Global Management from Antwerp Management School.

Ivan Grishchenko is a Global Pricing Director at Novo Nordisk in Copenhagen, where he has worked since 2024. Before joining Novo Nordisk, he was an Engagement Manager at McKinsey & Company in Copenhagen and spent more than a decade in strategy roles across the Pharma, MedTech, and Healthcare industries. Ivan holds an MBA from INSEAD and completed executive education at London Business School and Harvard Business School.

Omar Bringas is an independent advisor on commercial excellence and revenue growth strategy. He has almost two decades of international experience in pricing, revenue growth management and commercial transformation across medtech, FMCG and industrial sectors. Until 2025 he was Director of Commercial Excellence at Sonova Group, where he led its commercial transformation programme, including pricing, discount harmonisation and go-to-market changes across key European markets. He previously held commercial excellence and transformation roles at Aliaxis and Franke. Before that he spent four years as a Consulting Manager at Simon-Kucher & Partners, setting up revenue growth management functions for consumer goods companies in Europe and Latin America. He holds an MBA from Esade and completed executive education in strategy at Harvard Business School.

Ranjit Gill is Chief Information Officer of AAH, the UK pharmaceutical wholesaler formerly part of McKesson UK, where he has sat on the executive board since 2018. He has more than twenty years of experience leading technology-enabled business transformation in healthcare, retail and consumer goods. Before AAH he was UK Group IT Director at Müller UK & Ireland and IT Director for Retail at Boots UK, responsible for retail, supply chain and SAP systems. Earlier he was an Account Director at HCL, leading a global SAP transformation for a major pharmaceutical client. He spent five years at Cadbury, where he led IT integration of group functions following Kraft’s acquisition.

Silvia Antonelli is Senior Director of Price, Reimbursement and Access for Italy at Eli Lilly and Company. She has spent more than sixteen years at Lilly, moving from account management and quality improvement into pricing and access. She led price, reimbursement and access for Lilly’s autoimmune portfolio in Italy and worked as a payer strategist at subnational level, launching products in autoimmune disease and migraine. She later represented European payer perspectives on early-stage pipeline assets and business development deals in Lilly’s international new product planning team. Before her current role she was Senior Director for Diabetes and Biomedicine. She has co-authored health economics studies in psoriasis and rheumatoid arthritis, and regularly lectures on market access to students on SDA Bocconi’s MIHMEP master’s programme.

Daniela Barbosa Campos is Senior Manager, Global Strategic Access and Pricing at Boehringer Ingelheim, where she shapes global pricing and access strategy and supports launch decisions across markets. She has more than twenty years of experience in the pharmaceutical industry. Before her global role she spent over five years as Head of Market Access for Boehringer Ingelheim in Brazil, leading HTA, pricing, reimbursement and value communication, and engaging directly with national and subnational payers across public and private systems. Earlier she held market access, business development and innovation roles at AstraZeneca, Hypera, Bayer and Schering in Brazil.

Gianfranco Parlato is Global Head of Value Access, Pricing and Policy for Cardiometabolic and Venous Diseases at Servier in Paris. He has a particular focus on therapeutic adherence as a driver of value and health system sustainability and is a member of the EFPIA Cardiovascular Health Platform.

He brings more than 20 years of experience in pricing, market access and revenue management across the pharmaceutical industry and consulting management. Before his current role, he served as Servier’s Global Head of Pricing Excellence, following senior roles at Simon-Kucher, Zoetis and Pfizer. He studied economics at the University of Naples Federico II, completed executive education at ESCP and is a Certified Pricing Professional.

Karolina Bieniek is Strategic Tender Innovation Lead at Sanofi in Lyon. She leads the strategy for Sanofi’s tender digital ecosystem, building data analytics and GenAI capabilities, and develops upskilling programmes and digital tools for tender teams. She has spent more than fourteen years at Sanofi, almost all of it in vaccines. As Global Vaccines Trade Head she ran the worldwide review of commercial policy, managed global key accounts and led the development of new business models, including e-commerce. Before that she held global and regional marketing roles at Sanofi Pasteur covering Africa, the Middle East, Eastern Europe and Asia-Pacific. She holds an engineering and master’s degree in Management and Technology from Lodz University of Technology and completed an international business programme at emlyon business school.

Nicolas Tricca is Digital Head for Tender Management and Strategic Planning at Sanofi in Lyon. He leads a team of fifteen building digital, analytics and GenAI solutions for Sanofi’s tender business across its

global business units, which covers around €9 billion in related sales. He has spent more than 23 years at Sanofi, mostly in its vaccines business. There he led data and digital initiatives, ran regional demand management and S&OP for China, Japan and Asia-Pacific, and headed industrial supply chain across eight plants. He began his career in manufacturing, leading a production unit at Beiersdorf and industrialising new processes at FCI Electronics. He is an engineer by training.

Arnout Kruijer is Sales Director for Benelux and the Nordics at Enable, where he works with manufacturers, distributors and retailers to improve how they manage rebates, commercial incentives and pricing execution. He has more than twenty years of experience in B2B sales and advisory, from advising CIOs at Gartner to leading regional growth for scale-ups. Before joining Enable he was Sales Director at PG Forsta (now part of Qualtrics). He previously led sales at the AI and automation start-up FlowX.AI, enterprise sales in Benelux at Coursera and Benelux expansion at Bizagi. He holds a degree in Economics from Erasmus University Rotterdam.

Ruven is a Principal and Chief Commercial Officer at Marbls based out of Switzerland and has worked more than 19 years in Life Sciences in European and International markets with a primary focus in Pricing, Contracting, Tendering and Commercial Excellence. Ruven began his early career working in industry for Top 5 pharmaceutical manufacturers in tendering, contracting, and commercial effectiveness, from local to global roles. After which, Ruven joined HighPoint Solutions where he started and led consulting services in Europe for Global Pricing, Contracting and Tender Management. Ruven was responsible for developing teams, creating solutions, business development and project oversight as well as delivering services across clients from pharma, medical device to biosimilar & generic manufacturers. In addition, he was responsible for managing the international partnerships and Thought Leadership initiatives. Throughout the acquisition by IQVIA, Ruven became in charge of the legacy European HighPoint team. Ruven’s focus continues in Global Pricing, Contracting & Tender Management and Commercial Excellence, as well as the Commercial Strategy of Marbls.

Alan has spent close to 20 years doing commercial work for the life sciences industry. His experience includes creating innovative solutions for global pricing and access, including work on price optimization, global data collection and analysis, and the use of advanced algorithms to support commercial decisions, including pricing.

Alan has shared his expertise and insight and has spoken extensively at a number of pharmaceutical conferences on drug and device pricing. He was previously the CEO of Alliance Life Sciences and prior to that held positions as vice president in life sciences at Adjoined/Capgemini and as managing officer in Andersen Consulting, where he led a number of large technology projects.

Alan is a graduate of Princeton University.

Maarten is leading EY-Parthenon’s Pricing Hub, specializing in Commercial Strategy & Pricing with 18+ years of industry and consulting experience across multiple sectors. He has led pricing transformations, optimization programs, and value-based pricing initiatives for global and regional players. Known for his pragmatic, co-design approach, he focuses on delivering impactful and implementable strategies. Maarten is also a frequent keynote speaker and guest lecturer.

Thomas is an Executive Director at EY-Parthenon, specializing in Commercial Strategy & Pricing, with +12 years of consulting experience and a strong focus on the life sciences industry. He is a regular speaker at conferences and executive trainings, where he shares insights on value-based pricing, commercial transformation, innovative go-to-market models, and shifts in the European market landscape.

Nico Bacharidis is the Chief Commercial Officer at Cube RM and leverages over 13 years of experience across local, regional, and global roles within the pharmaceutical industry. He has built and led the global team at Pfizer responsible for the management of the worldwide Tender and Contracting business. Nico is one of the few people who have personally built and lead a truly global and x-functionally aligned tender organization in big pharma.

Marc Abels is a Partner at Monitor Deloitte and leads Deloitte Belgium’s Life Sciences and Healthcare practice. He also leads its Strategy and Analytics team of more than 300 consultants. He has spent his

whole career at Deloitte, joining in 2000, and is one of its leading pricing experts in Europe. He advises pharmaceutical and medtech companies on pricing and margin improvement, go-to-market strategy, new product introductions and commercial transformation. He regularly speaks at pricing conferences, including the Professional Pricing Society and the European Pricing Platform, and recently spoke on China’s rise as a biotech innovator at the annual bio.be/essenscia event. He holds an MBA from INSEAD and an MSc in Economics from Hasselt University.

Sandra Garitonandia is Manager Global Industry and Life Sciences Industry Principal at Vistex, the revenue management software company, based in Barcelona. She leads Vistex’s global industry team for manufacturing-related sectors while continuing to advise life sciences companies on revenue management. She has spent more than a decade at Vistex in solution advisory, solution architecture and business development roles, with a break in 2018 to lead the trade stream of Sanofi’s SHIFT programme. Before joining Vistex she spent nearly five years at Ipsen in Paris and Barcelona as Competence Center Leader for Sales and Distribution.

Nick Boyer is Senior Director, Strategic Consulting at Conga, where he helps B2B companies improve margins through pricing strategy, price optimisation and CPQ. He has more than fifteen years of experience in pricing technology, almost all of it at PROS, whose B2B business is now part of Conga. There he moved from project delivery and leading the EMEA professional services team to heading a strategic consulting team across the UK, Germany, France and Sweden. Before that he led commercial and systems transformation programmes at Tarmac, Alliance Boots and Saint-Gobain, including a commercial programme at Tarmac that introduced price segmentation, price guidance and a customer price waterfall. A chartered accountant by training, he speaks regularly on pricing, most recently on AI adoption in pricing teams and on fair and ethical pricing.

Bridging the gap between business and technology. An entrepreneur, founder and CEO at Cube RM, founder of BEL, passionately leading as well as being part of a successful and productive team.

Serving the Technology industry by designing and delivering complex solutions and high-end services to the Life Sciences and Media industries.

Specializing in AI solutions in Tender Management, CPQ, Revenue Management, MIS, CRM and e-Detailing systems as well as excelling in services and consulting for Enterprise Mobility, Data services, Business Intelligence and Closed Loop Marketing.